Mersana Therapeutics (MRSN) News Today → Trending Stocks Sent To You In Real Time (From Huge Alerts) (Ad) Free MRSN Stock Alerts $4.49 +0.19 (+4.42%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Recommendation of "Moderate Buy" from Analystsamericanbankingnews.com - March 25 at 3:14 AMMersana Therapeutics (NASDAQ:MRSN) Stock Price Down 3.2%marketbeat.com - March 20 at 1:51 PMJPMorgan Chase & Co. Upgrades Mersana Therapeutics (NASDAQ:MRSN) to "Neutral"americanbankingnews.com - March 20 at 5:52 AMThe Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Expertsmarkets.businessinsider.com - March 19 at 1:44 PMMersana Therapeutics (NASDAQ:MRSN) Shares Gap Up to $4.86marketbeat.com - March 19 at 11:52 AMMersana Therapeutics (NASDAQ:MRSN) Raised to Neutral at JPMorgan Chase & Co.marketbeat.com - March 19 at 8:35 AMWalleye Capital LLC Has $2.57 Million Holdings in Mersana Therapeutics, Inc. (NASDAQ:MRSN)marketbeat.com - March 17 at 4:20 AMMersana Therapeutics (NASDAQ:MRSN) Shares Down 6.4% marketbeat.com - March 14 at 1:23 PMMersana Therapeutics (NASDAQ:MRSN) Trading 6.3% Higher Following Analyst Upgrademarketbeat.com - March 3 at 1:04 AMAffinity Asset Advisors LLC Invests $3.62 Million in Mersana Therapeutics, Inc. (NASDAQ:MRSN)marketbeat.com - March 2 at 11:02 AMMersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 8:23 PMGuggenheim Upgrades Mersana Therapeutics (MRSN)nasdaq.com - March 1 at 10:22 AMBuy Rating Affirmed for Mersana Therapeutics Amid Promising ADC Developments and Upcoming Milestonesmarkets.businessinsider.com - March 1 at 10:22 AMTruist Securities Upgrades Mersana Therapeutics (MRSN)msn.com - March 1 at 10:22 AMWedbush Upgrades Mersana Therapeutics (MRSN)msn.com - March 1 at 10:22 AMMersana Therapeutics (NASDAQ:MRSN) Shares Up 6.3% After Analyst Upgrademarketbeat.com - March 1 at 10:15 AMMersana Therapeutics, Inc. (NASDAQ:MRSN) Expected to Earn Q1 2025 Earnings of ($0.23) Per Sharemarketbeat.com - March 1 at 8:29 AMExpert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analystsmarkets.businessinsider.com - February 29 at 1:46 PMMersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 29 at 1:46 PMTruist Financial Upgrades Mersana Therapeutics (NASDAQ:MRSN) to Buymarketbeat.com - February 29 at 9:29 AMRobert W. Baird Raises Mersana Therapeutics (NASDAQ:MRSN) Price Target to $5.00marketbeat.com - February 29 at 8:33 AMGuggenheim gets more bullish on Mersana Therapeutics, upgrades sharesrealmoney.thestreet.com - February 29 at 7:46 AMMersana Therapeutics Full Year 2023 Earnings: Revenues Disappointfinance.yahoo.com - February 29 at 7:46 AMAn Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervaluedfinance.yahoo.com - February 29 at 7:46 AMQ4 2023 Mersana Therapeutics Inc Earnings Callfinance.yahoo.com - February 29 at 2:44 AMMersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - February 28 at 11:42 AMMersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07Mmsn.com - February 28 at 11:42 AMMersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 28 at 11:42 AMMersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 28 at 11:42 AMMersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 28 at 7:00 AMHere's what Wall Street expects from Mersana Therapeutics's earningsmarkets.businessinsider.com - February 27 at 5:41 PMMersana Therapeutics Q4 2023 Earnings Previewmsn.com - February 27 at 5:41 PMMersana Therapeutics to Present at Upcoming Investor Conferencesglobenewswire.com - February 27 at 8:01 AMMersana Therapeutics Stock (NASDAQ:MRSN) Dividends: History, Yield and Datesbenzinga.com - February 27 at 7:40 AMMersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024finance.yahoo.com - February 21 at 12:06 PMMersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024globenewswire.com - February 21 at 8:00 AMMersana Therapeutics, Inc. (MRSN)finance.yahoo.com - February 21 at 7:06 AMMersana Therapeutics, Inc. (MRSN) May Report Negative Earnings: Know the Trend Ahead of Q4 Releasefinance.yahoo.com - February 20 at 4:04 PMShort Interest in Mersana Therapeutics, Inc. (NASDAQ:MRSN) Drops By 10.0%marketbeat.com - February 16 at 6:21 PMRhenman & Partners Asset Management AB Sells 378,300 Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN)marketbeat.com - February 12 at 1:01 PMMersana Therapeutics Inc (MRSN)uk.investing.com - February 10 at 7:41 PMLos Angeles Capital Management LLC Acquires New Stake in Mersana Therapeutics, Inc. (NASDAQ:MRSN)marketbeat.com - February 5 at 4:54 AMMersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Hold" by Brokeragesmarketbeat.com - February 4 at 3:17 AMMersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conferencefinance.yahoo.com - February 1 at 8:42 AM3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024msn.com - January 22 at 6:18 PMMersana Therapeutics: A Bottom-Feeding Gamble Of A Stockseekingalpha.com - January 11 at 8:13 AMMersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Rating of "Hold" by Brokeragesmarketbeat.com - January 10 at 4:14 AMMersana Therapeutics announces business updates, expected 2024 milestonesmsn.com - January 5 at 2:57 PMMersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 5 at 2:57 PMThe past three years for Mersana Therapeutics (NASDAQ:MRSN) investors has not been profitablefinance.yahoo.com - January 2 at 10:47 AM Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. MRSN Media Mentions By Week MRSN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRSN News Sentiment▼0.500.61▲Average Medical News Sentiment MRSN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRSN Articles This Week▼32▲MRSN Articles Average Week Get Mersana Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MRSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NKTX News Today LXRX News Today OPK News Today SIGA News Today CMPS News Today IGMS News Today ANAB News Today NRIX News Today ALXO News Today FULC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRSN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mersana Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.